Matthew Prettyjohns

Statistics

Publications

Citations

248

H-Index

Active since

2011

Affiliations

Cardiff University(Current)

Matthew Prettyjohns is an author at Cardiff University specializing in cost-effectiveness analysis, pharmacoeconomics, and cost-effectiveness modeling.

ORCID

Publications per year

2011–2020

Publications

Prostate cancer: summary of updated NICE guidance

John D. Graham, Kimberley Cann, Elise Hasler et al. · BMJ · 2014 · 108 citations

Medicine, Oncology, Urology +13

Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance

Mike Bennett, John D. Graham, Mia Schmidt‐Hansen et al. · BMJ · 2012 · 39 citations

Nursing, Oncology, Pharmacotherapy +17

Transoral laser microsurgery <i>versus</i> radiation therapy in the management of T1 and T2 laryngeal glottic carcinoma: which modality is cost‐effective within the <scp>UK</scp>?

Matthew Prettyjohns, Stuart C. Winter, C. Kerawala et al. · Clinical Otolaryngology · 2016 · 31 citations

Medicine, Otolaryngology, Surgery +17

A cost-utility study of the use of pregabalin in treatment-refractory neuropathic pain

Jason Gordon, Steven Lister, Matthew Prettyjohns et al. · Journal of Medical Economics · 2011 · 20 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

The effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review

David Jarrom, Lauren Elston, Jennifer Washington et al. · medRxiv · 2020 · 20 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

1–5 of 7